Oril
  • Home
  • About us
    • Our Company
    • Corporate governance
    • Company reports
  • Our research
    • R&D strategy
    • Key results
    • Development pipeline
    • Intellectual property
  • Investor centre
    • Commercialisation strategy
    • Financing strategy
    • Downloads
  • News
  • Contact

Quarterly Update 4Q 2013 now available

The CEO Update for the fourth quarter of 2013 is now available from our Downloads section.

This entry was posted in Latest News on 05/02/2014 by The Bowery Group.

Post navigation

← Notice of extraordinary general meeting. Media Release: ORIL Receives Funding Boost →

News

  • > Letter to Shareholders re CEO

  • > Interim Financial Report – Half-Year Ended 31 Dec 2021

  • > Michael Wayte notice

News
  • > Letter to Shareholders re CEO
  • > Interim Financial Report – Half-Year Ended 31 Dec 2021
  • > Michael Wayte notice
  • > 2021 Financial Statements
Address

Registered Office
Oncology Research International Limited
Level 5, 45 St George Terrace,
Perth WA 6000 Australia

Links
  • > Home
  • > About us
  • > Investor Centre
  • > News
© Copyright 2015. Oncology Research International Limited.
> Website terms of use